Beneficial ownership — 13D / 13G
87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| NOVO HOLDINGS A/S | LXEO Lexeo Therapeutics, Inc. | 13G | 5.1% | Nov 15, 2023 | 2y |
| Charles & Potomac Capital, LLC | ONDS Ondas Inc. | 13D/A | 18.8% | Nov 15, 2023 | 2y |
| Daniel Kaufman | HROW Harrow, Inc. | 13G | 5.37% | Nov 15, 2023 | 2y |
| George Economou | SHIP Seanergy Maritime Holdings Corp. | 13D | 5.7% | Nov 14, 2023 | 2y |
| Ole Nielsen | TRUP Trupanion, Inc. | 13G | 5.6% | Nov 14, 2023 | 2y |
| Ariel Emanuel | TKO TKO Group Holdings, Inc. | 13D | 52.2% | Nov 14, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | THRX Theseus Pharmaceuticals, Inc. Common Stock | 13D | 7% | Nov 14, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | ACRS Aclaris Therapeutics, Inc. | 13G | 6.1% | Nov 14, 2023 | 2y |
| JAB Holdings B.V. | DNUT Krispy Kreme, Inc. | 13D/A | 44.42% | Nov 22, 2023 | 2y |
| Bellevue Capital Partners, LLC | NYC American Strategic Investment Co. | 13D/A | 46.5% | Nov 22, 2023 | 2y |
| René Holeček | VSTO Vista Outdoor Inc. | 13D/A | 5.7% | Nov 22, 2023 | 2y |
| Farragut Square Global Master Fund, LP | MRT Marti Technologies, Inc. | 13D/A | 13.3% | Nov 21, 2023 | 2y |
| KKR Asset Management LLC | FSK FS KKR Capital Corp | 13D/A | 4.9% | Nov 21, 2023 | 2y |
| Saba Capital Management, L.P. | BTX BlackRock Technology & Private Equity Term Trust | 13D/A | 16.18% | Nov 20, 2023 | 2y |
| Family Trading Inc. | TOPS Top Ships Inc. | 13D/A | 63.36% | Nov 20, 2023 | 2y |
| Frazier Life Sciences VIII, L.P. | ALPN Alpine Immune Sciences, Inc. Common Stock | 13D/A | 9.8% | Nov 20, 2023 | 2y |
| PAR Investment Partners, L.P. | GRPN Groupon, Inc. | 13G | 19.9% | Nov 20, 2023 | 2y |
| Redmile Group, LLC | AUGX Augmedix, Inc. Common Stock | 13D/A | 40.7% | Nov 20, 2023 | 2y |
| Saba Capital Management, L.P. | NXJ NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND | 13D/A | 12.24% | Nov 20, 2023 | 2y |
| Saba Capital Management, L.P. | FMN Federated Hermes Premier Municipal Income Fund | 13D/A | 10.54% | Nov 20, 2023 | 2y |
| Cannae Holdings, Inc. | PSFE Paysafe Ltd | 13D/A | 4.77% | Nov 20, 2023 | 2y |
| Martin J. Wygod | NSTG NanoString Technologies, Inc. | 13D/A | 1.49% | Nov 20, 2023 | 2y |
| JCP Investment Management, LLC | WHG Westwood Holdings Group Inc | 13D/A | 5.9% | Nov 20, 2023 | 2y |
| Robert Arsov | RUM RUM Group Inc. | 13D/A | 9.4% | Nov 18, 2023 | 2y |
| JAMES E. BESSER | SNWV SANUWAVE Health, Inc. | 13D/A | 33.86% | Nov 17, 2023 | 2y |
| Goldenwise Capital Group Ltd | JOB GEE Group Inc. | 13D/A | 4.9% | Nov 16, 2023 | 2y |
| GLAZER CAPITAL, LLC | CCF Chase Corporation | 13G/A | 0% | Nov 15, 2023 | 2y |
| FP Credit Partners II, L.P. | SATX SatixFy Communications Ltd. | 13G | 6.31% | Nov 15, 2023 | 2y |
| PharmaCyte Biotech, Inc. | FEMY Femasys Inc | 13D | 37% | Nov 14, 2023 | 2y |
| Divisar Capital Management LLC | SFIX Stitch Fix, Inc. | 13G | 5.6% | Nov 13, 2023 | 2y |
| Michael Singer | RNAC Cartesian Therapeutics, Inc. | 13D | 13.9% | Nov 13, 2023 | 2y |
| Murat Kalayoglu | RNAC Cartesian Therapeutics, Inc. | 13D | 19.9% | Nov 13, 2023 | 2y |
| Valence Investments SPV VI, LLC | CALC CalciMedica, Inc. | 13D/A | 16.4% | Nov 7, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | ABVX Abivax S.A. | 13G | 5.3% | Oct 24, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | LAB Standard Biotools Inc. | 13D/A | 9.5% | Oct 4, 2023 | 2y |
| Samsara BioCapital, L.P. | KDNY Chinook Therapeutics, Inc. Common Stock | 13D/A | 0% | Aug 11, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | BBIO BridgeBio Pharma, Inc. | 13D/A | 15.7% | Jul 18, 2023 | 2y |
| Jacobsen Per A. | BLIN Bridgeline Digital, Inc. | 13G/A | 6.6% | Nov 21, 2023 | 2y |
| Quek Leng Chuang | OIO OIO Group | 13D/A | 31.31% | Nov 20, 2023 | 2y |
| Lynrock Lake LP | ALLT Allot Ltd. | 13D/A | 22.94% | Nov 20, 2023 | 2y |
| Spectrum Equity VII, L.P. | GDRX GoodRx Holdings, Inc. | 13D/A | 31% | Nov 20, 2023 | 2y |
| YORKTOWN ENERGY PARTNERS IX, L.P. | METC Ramaco Resources, Inc. | 13D/A | 11.69% | Nov 17, 2023 | 2y |
| Altai Capital Management, L.P. | OSPN OneSpan Inc. | 13D/A | 4.2% | Nov 17, 2023 | 2y |
| Saba Capital Management, L.P. | VTN Invesco Trust for Investment Grade New York Municipals | 13D/A | 12.01% | Nov 17, 2023 | 2y |
| BAKER BROS. ADVISORS LP | MDGL Madrigal Pharmaceuticals, Inc. | 13D/A | 9.99% | Nov 17, 2023 | 2y |
| I.B.F Management Ltd. | ADXS Advaxis, Inc. | 13D/A | 83.6% | Nov 17, 2023 | 2y |
| Yorktown Energy Partners XI, L.P. | METC Ramaco Resources, Inc. | 13D/A | 11.64% | Nov 17, 2023 | 2y |
| EcoR1 Capital, LLC | ATRA Atara Biotherapeutics, Inc. | 13G | 9.9% | Nov 16, 2023 | 2y |
| Mr. Bruce Flatt | BNT Brookfield Wealth Solutions Ltd. | 13D/A | 19.99% | Nov 16, 2023 | 2y |
| Partners Value Investments L.P. | BNT Brookfield Wealth Solutions Ltd. | 13D/A | 9.9% | Nov 16, 2023 | 2y |